Thyrotropin receptor antibodies (TRAbs) play a significant role in the course of
hepatic dysfunction (HDF) in patients with Graves’ disease (GD).
However, few studies have considered the factors that influence the
relationships among TRAbs, thyroid hormone levels, and hepatic function in
subjects with newly diagnosed GD. Here we investigated the associations of TRAbs
with thyroid hormones and hepatic function and assessed potential factors that
can influence these associations among patients with GD. A total of 368 patients
newly diagnosed with GD were collected in this cross-sectional study. Patients
who had received antithyroid drugs, radioactive iodine, or surgery were
excluded. Levels of TRAbs and thyroid hormones and hepatic function were
recorded. Linear and binary logistic regression analysis models were applied to
investigate associations among these variables after adjusting for confounding
characteristics. There was a significant difference in TRAbs indices between the
HDF and normal hepatic function groups (p <0.05). After adjusting for
confounders, the relationship between TRAbs and thyroid hormones was nonlinear,
showing a curve with an initial positive slope and a subsequent flattening (p
<0.05). Higher TRAbs were associated with HDF [odds ratio (OR) 1.036,
95% confidence interval (CI) 1.018–1.053 per 1-IU/l
increase]. These associations were modified by age, but not by gender, smoking
status, Graves’ orbitopathy, thyroid-peroxidase antibody levels, or
thyroglobulin antibody levels. In younger patients, increasing TRAbs were
correlated with higher thyroid hormones and HDF (OR 1.034, 95% CI
1.017–1.052) per1-IU/l increase). In older patients, TRAbs were
not correlated with thyroid hormones or HDF (OR 1.024, 95% CI
0.993–1.056) per 1-IU/l increase. Age can affect the impact of
TRAbs on thyroid hormone levels and hepatic function in GD. TRAb measurement can
have good predictive value in younger patients.